Instrument Inactif

Communiqués Soliton, Inc.

Actions

SOLY

US8342511008

Equipement et technologie médicale avancés

Communiqués

16/12/21	SOLITON, INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
16/12/21	Allergan Aesthetics Completes Acquisition of Soliton	PR
14/12/21	SOLITON, INC. : Other Events (form 8-K)	AQ
12/11/21	SOLITON, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
09/11/21	SOLITON, INC. : Other Events (form 8-K)	AQ
12/08/21	SOLITON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
06/08/21	SOLITON, INC. : Other Events (form 8-K)	AQ
20/07/21	SOLITON, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
02/07/21	SOLITON, INC. : Other Events (form 8-K)	AQ
13/05/21	SOLITON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
12/05/21	SOLITON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Soliton, Inc. - SOLY	BU
12/05/21	Soliton : Reports First Quarter 2021 Results	PR
12/05/21	Soliton : SUPPORT AGREEMENT (Form 8-K)	PU
10/05/21	SOLITON, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events (form 8-K)	AQ
10/05/21	Soliton : Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio	PR
05/05/21	Soliton : Introducing RESONIC™	PR
04/05/21	Soliton : to Report First Quarter 2021 Financial Results on May 13, 2021	PR
29/04/21	Soliton : Receives FDA Clearance of Special 510(k)	PR
16/04/21	SOLITON, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
15/04/21	Soliton : Provides Special 510(k) and Commercialization Update	PR
15/03/21	SOLITON, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
11/03/21	Soliton : to Participate in Three Upcoming Healthcare Conferences	PR
09/03/21	Soliton : Announces Initiation of Second Animal Study for Potential RAP Treatment of Liver Fibrosis	PR
04/03/21	Soliton : Reports Fourth Quarter and Full Year 2020 Results	PR
02/03/21	Soliton : Selects RESONIC™ As Brand Name for FDA-Cleared Rapid Acoustic Pulse Device	PR